Nesiritide for outpatient treatment of heart failure

被引：0
|
作者：
Bauer, EB [1 ]
Randazzo, MA [1 ]
机构：
[1] St Elizabeth Hosp, Belleville, IL 62234 USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2005年 / 62卷 / 24期
关键词：
D O I：
10.2146/ajhp050199
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Although outpatient care has become vital in the management of chronic heart failure, no study has shown that nesiritide contributes safely to that care. The authors of this commentary recommend that, until nesiritide's safety profile in outpatients has been defined, the drug should be used only in inpatients whose acute decompensated heart failure has not responded to adequate attempts with diuretics and vasodilators.
引用
收藏
页码：2639 / 2642
页数：4
相关论文
共 50 条
  • [41] Outpatient nesiritide for decompensated LV failure - Case studies of 17 patients
    Altschul, L
    Masciello, M
    Massaro, G
    ADVANCES IN HEART FAILURE, 2002, : 377 - 382
  • [42] Handheld echocardiography in outpatient heart failure clinics: facilitating prompt heart failure treatment
    Somarakis, K. Konstantinos
    Clayton, L.
    Kadani, Z.
    Loke, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 92 - 92
  • [43] Nesiritide associated with higher risk of death in heart failure
    不详
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2005, 3 (03) : 373 - 373
  • [44] Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
    O'Connor, C. M.
    Starling, R. C.
    Hernandez, A. F.
    Armstrong, P. W.
    Dickstein, K.
    Hasselblad, V.
    Heizer, G. M.
    Komajda, M.
    Massie, B. M.
    McMurray, J. J. V.
    Nieminen, M. S.
    Reist, C. J.
    Rouleau, J. L.
    Swedberg, K.
    Adams, K. F., Jr.
    Anker, S. D.
    Atar, D.
    Battler, A.
    Botero, R.
    Bohidar, N. R.
    Butler, J.
    Clausell, N.
    Corbalan, R.
    Costanzo, M. R.
    Dahlstrom, U.
    Deckelbaum, L. I.
    Diaz, R.
    Dunlap, M. E.
    Ezekowitz, J. A.
    Feldman, D.
    Felker, G. M.
    Fonarow, G. C.
    Gennevois, D.
    Gottlieb, S. S.
    Hill, J. A.
    Hollander, J. E.
    Howlett, J. G.
    Hudson, M. P.
    Kociol, R. D.
    Krum, H.
    Laucevicius, A.
    Levy, W. C.
    Mendez, G. F.
    Metra, M.
    Mittal, S.
    Oh, B. -H.
    Pereira, N. L.
    Ponikowski, P.
    Wilson, W. H.
    Tanomsup, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (01): : 32 - 43
  • [45] A prospective evaluation of intravenous nesiritide in pediatric heart failure
    Jefferies, JL
    Denfield, SW
    Dreyer, WJ
    Price, JF
    Kim, JJ
    Dimas, VV
    Clunie, S
    Smith, EO
    McMahon, CJ
    Wann, TI
    Moffett, BS
    Towbin, JA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 315A - 315A
  • [46] Intermittent nesiritide therapy in outpatients with chronic heart failure
    Sheikh-Taha, M
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (02) : 196 - 198
  • [47] ETOZOLIN IN OUTPATIENT TREATMENT WITH CONGESTIVE HEART-FAILURE
    KOPP, H
    MEDIZINISCHE WELT, 1979, 30 (15): : 576 - 581
  • [48] Outpatient treatment of heart failure decompensation with subcutaneous furosemide
    Robles Mezcua, A.
    Martin De La Rosa, A. P.
    Cruzado Alvarez, C.
    Jimenez Rubio, C.
    Perez Cabeza, A. I.
    Garcia Pinilla, J. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 248 - 249
  • [49] The evolving role of nesiritide in advanced or decompensated heart failure
    Zineh, I
    Schofield, RS
    Johnson, JA
    PHARMACOTHERAPY, 2003, 23 (10): : 1266 - 1280
  • [50] Nesiritide reduces mortality and rehospitalization in decompensated heart failure?
    Bernardo, Wanderley Marques
    Moreira, Fabio Tanzillo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2012, 58 (02): : 133 - 134
12345